See my earlier post...the company said on 19th December that they are considering funding options for the testing and development costs approximating USD4m. One of those options and the most obvious one would be a placement. That, in my opinion has kept the price from advancing at the rate it would normally do.
As I said I am hoping the discount is minimal having regard to the obvious upside potential of the discoveries. I think there is even a remote possibility that a placement would be done at market or a slight premium (very doubtful though).
In either event, I am quite happy that the issue of funding of the expenses will be resolved and the air cleared to allow the stock price to appreciate the way it should have.
regards
DF
trading halt..!!!!!!!!!!!!!!!!, page-12
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add STX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.0¢ |
Change
0.005(2.56%) |
Mkt cap ! $572.1M | |||
| Open | High | Low | Value | Volume |
| 19.5¢ | 20.0¢ | 19.0¢ | $1.339M | 6.792M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 23 | 674181 | 19.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 741329 | 6 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| STX (ASX) Chart |